Northpond Ventures
Cambridge, Massachusettsnpv.vc
Overview
Northpond Ventures is a science-driven venture capital firm that invests in breakthrough science and technology businesses across the biotechnology, diagnostics, life science tools, and digital health sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kytopen | Apr 2026 | Series B | Co-investor |
| Mestag Therapeutics | Mar 2026 | Early Funding | Co-investor |
| VIZGEN | Jan 2026 | Series E | Lead |
| Culture Biosciences | Dec 2025 | Series C | Co-investor |
| Elephas | Nov 2025 | Series B Extension | Co-investor |
Key People
Sharon Kedar
Co-Founder and Partner
Mike Rubin
Founder and CEO
Ingo Chakravarty
Operating Partner
Andrea Jackson
Partner
Elias Quijano
Principal
Lucy Coassin
Principal
Maddie Maloney
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.